{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:18:04Z","timestamp":1790486284075,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.canep.2020.101707","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T12:52:57Z","timestamp":1585227177000},"page":"101707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Levothyroxine treatment is associated with an increased relative risk of overall and organ specific incident cancers \u2013 a cohort study of the Swedish population"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5169-2965","authenticated-orcid":false,"given":"Per","family":"W\u00e4ndell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel C.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.canep.2020.101707_bib0005","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.amjcard.2017.08.013","article-title":"Comparison of mortality and nonfatal cardiovascular events in adults with atrial fibrillation with versus without levothyroxine treatment","volume":"120","author":"Wandell","year":"2017","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.canep.2020.101707_bib0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jez.1402320311","article-title":"Thyroidal influence on body growth","volume":"232","author":"King","year":"1984","journal-title":"J. Exp. Zool."},{"issue":"16","key":"10.1016\/j.canep.2020.101707_bib0015","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.2174\/1381612823666170206124255","article-title":"Congenital hypothyroidism: facts, facets & therapy","volume":"23","author":"Kollati","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"10.1016\/j.canep.2020.101707_bib0020","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/bjs.10284","article-title":"Thyroid function and survival following breast cancer","volume":"103","author":"Brandt","year":"2016","journal-title":"Br. J. Surg."},{"issue":"3","key":"10.1016\/j.canep.2020.101707_bib0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5306\/wjco.v5.i3.503","article-title":"Triiodothyronine and breast cancer","volume":"5","author":"De Sibio","year":"2014","journal-title":"World J. Clin. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.canep.2020.101707_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2007.12.008","article-title":"Effects of thyroid hormones on human breast cancer cell proliferation","volume":"109","author":"Hall","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"12","key":"10.1016\/j.canep.2020.101707_bib0035","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1210\/jc.2016-2104","article-title":"Thyroid function and cancer risk: The Rotterdam study","volume":"101","author":"Khan","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.canep.2020.101707_bib0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13058-018-1017-8","article-title":"Thyroid hormones and breast cancer association according to menopausal status and body mass index","volume":"20","author":"Ortega-Olvera","year":"2018","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.canep.2020.101707_bib0045","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/bcr2587","article-title":"Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women","volume":"12","author":"Tosovic","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canep.2020.101707_bib0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fendo.2019.00059","article-title":"Thyroid hormones and cancer: A comprehensive review of preclinical and clinical studies","volume":"10","author":"Krashin","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.canep.2020.101707_bib0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00228-010-0884-4","article-title":"Prevalence of hypothyroidism in Finland--a nationwide prescription study","volume":"67","author":"Virta","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.canep.2020.101707_bib0060","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/europace\/eut019","article-title":"Neighbourhood deprivation and hospitalization for atrial fibrillation in Sweden","volume":"15","author":"Zoller","year":"2013","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.canep.2020.101707_bib0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00404-018-4837-y","article-title":"Levothyroxine use and the risk of breast cancer: a nation-wide population-based case-control study","volume":"298","author":"Wu","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.canep.2020.101707_bib0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-15-0989","article-title":"Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study","volume":"174","author":"Sogaard","year":"2016","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.canep.2020.101707_bib0075","first-page":"1","article-title":"Hypothyroidism as a risk factor for cancer: a systematic review and implications for future studies","volume":"4","author":"Trodello","year":"2017","journal-title":"Cancer Sci. Res. Open Access"},{"key":"10.1016\/j.canep.2020.101707_bib0080","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fendo.2018.00655","article-title":"Levothyroxine replacement improves oxidative status in primary hypothyroidism","volume":"9","author":"Masullo","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"15","key":"10.1016\/j.canep.2020.101707_bib0085","doi-asserted-by":"crossref","first-page":"24237","DOI":"10.18632\/oncotarget.10757","article-title":"Crosstalk between integrin alphavbeta3 and ERalpha contributes to thyroid hormone-induced proliferation of ovarian cancer cells","volume":"8","author":"Hsieh","year":"2017","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.canep.2020.101707_bib0090","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/onc.2015.262","article-title":"The thyroid hormone-alphavbeta3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation","volume":"35","author":"Shinderman-Maman","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canep.2020.101707_bib0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jcph.972","article-title":"Thyroxin use is associated with increased risk of thyroid cancer in patients with hypothyroidism","volume":"58","author":"Hung","year":"2018","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.canep.2020.101707_bib0100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/fampra\/cmt033","article-title":"Most common diseases diagnosed in primary care in Stockholm, Sweden, in 2011","volume":"30","author":"Wandell","year":"2013","journal-title":"Fam. Pract."},{"issue":"7","key":"10.1016\/j.canep.2020.101707_bib0105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"3","key":"10.1016\/j.canep.2020.101707_bib0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.17849\/insm-47-03-143-158.1","volume":"47","author":"Milano","year":"2018","journal-title":"J. Insur. Med."},{"issue":"10061","key":"10.1016\/j.canep.2020.101707_bib0115","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","article-title":"Thyroid cancer","volume":"388","author":"Cabanillas","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.canep.2020.101707_bib0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1507\/endocrj.EJ17-0026","article-title":"Natural history of thyroid cancer [Review]","volume":"64","author":"Takano","year":"2017","journal-title":"Endocr. J."},{"issue":"1","key":"10.1016\/j.canep.2020.101707_bib0125","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12957-018-1436-0","article-title":"Review of the possible association between thyroid and breast carcinoma","volume":"16","author":"Dong","year":"2018","journal-title":"World J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.canep.2020.101707_bib0130","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv084","article-title":"Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk","volume":"107","author":"Boursi","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.canep.2020.101707_bib0135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jnci\/djq042","article-title":"A case-control study of levothyroxine and the risk of colorectal cancer","volume":"102","author":"Rennert","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.canep.2020.101707_bib0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40261-018-0740-3","article-title":"Effect of levothyroxine treatment on incident dementia in adults with atrial fibrillation and hypothyroidism","volume":"39","author":"Wandell","year":"2019","journal-title":"Clin. Drug Invest."},{"issue":"10","key":"10.1016\/j.canep.2020.101707_bib0145","first-page":"1821","article-title":"Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened","volume":"20","author":"Friedman","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.canep.2020.101707_bib0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.canep.2020.101707_bib0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish cancer register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782120300412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782120300412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:25:35Z","timestamp":1761801935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782120300412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":31,"alternative-id":["S1877782120300412"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2020.101707","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levothyroxine treatment is associated with an increased relative risk of overall and organ specific incident cancers \u2013 a cohort study of the Swedish population","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2020.101707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101707"}}